REFERENCES
- 1
Lacroix R, Robert S, Poncelet P, Dignat-George F.
Overcoming limitations of microparticle measurement by flow cytometry.
Semin Thromb Hemost.
2010;
36(8)
807-818
- 2
Zwicker J I.
Impedance-based flow cytometry for the measurement of microparticles.
Semin Thromb Hemost.
2010;
36(8)
819-823
- 3
Gabriel D, Giordano K.
Microparticle sizing and counting using light scattering methods.
Semin Thromb Hemost.
2010;
36(8)
824-832
- 4
Morel O, Toti F, Jesel L, Freyssinet J-M.
Mechanisms of microparticle generation: on the trail of the mitochondrion!.
Semin Thromb Hemost.
2010;
36(8)
833-844
- 5
Little K M, Smalley D M, Harthun N L, Ley K.
The plasma microparticle proteome.
Semin Thromb Hemost.
2010;
36(8)
845-856
- 6
Davizon P, Munday A D, López J A.
Tissue factor, lipid rafts, and microparticles.
Semin Thromb Hemost.
2010;
36(8)
857-864
- 7
Key N, Mackman N.
Tissue factor and its measurement in whole blood, plasma, and microparticles.
Semin Thromb Hemost.
2010;
36(8)
865-875
- 8
Jy W, Horstman L H, Ahn Y S.
Microparticle size and its relation to composition, functional activity, and clinical
significance.
Semin Thromb Hemost.
2010;
36(8)
876-880
- 9
Flaumenhaft R, Mairuhu A TA, Italiano Jr J E.
Platelet and megakaryocyte-derived microparticles.
Semin Thromb Hemost.
2010;
36(8)
881-887
- 10
Rak J.
Microparticles in cancer.
Semin Thromb Hemost.
2010;
36(8)
888-906
- 11
Amabile N, Rautou P-E, Tedgui A, Boulanger C M.
Microparticles: key protagonists in cardiovascular disorders.
Semin Thromb Hemost.
2010;
36(8)
907-916
- 12
Kwaan H C, Rego E M.
Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia.
Semin Thromb Hemost.
2010;
36(8)
917-924
- 13
Nieuwland R, van der Post J AM, Lo C AR, Kenter G G, Sturk A.
Microparticles and exosomes in gynecological neoplasias.
Semin Thromb Hemost.
2010;
36(8)
925-930
- 14
Aird W C, Kwaan H C.
Under-recognized significance of endothelial heterogeneity: hemostasis, thrombosis,
and beyond.
Semin Thromb Hemost.
2010;
36(3)
225-226
- 15
Kwaan H C.
Hemostatic dysfunction in malignant hematologic disorders.
Semin Thromb Hemost.
2007;
33(4)
301-302
- 16
Lippi G, Favaloro E J, Franchini M, Guidi G C.
Milestones and perspectives in coagulation and hemostasis.
Semin Thromb Hemost.
2009;
35(1)
9-22
- 17
Enjeti A K, Lincz L F, Seldon M.
Microparticles in health and disease.
Semin Thromb Hemost.
2008;
34(7)
683-691
- 18
Zwicker J I.
Tissue factor-bearing microparticles and cancer.
Semin Thromb Hemost.
2008;
34(2)
195-198
- 19
Blann A, Shantsila E, Shantsila A.
Microparticles and arterial disease.
Semin Thromb Hemost.
2009;
35(5)
488-496
- 20
Mina A, Favaloro E J, Mohammed S, Koutts J.
A laboratory evaluation into the short activated partial thromboplastin time.
Blood Coagul Fibrinolysis.
2010;
21(2)
152-157
Emmanuel J FavaloroPh.D. M.A.I.M.S.
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR),
Westmead Hospital
WSAHS, Westmead, NSW 2145, Australia
Email: emmanuel.favaloro@swahs.health.nsw.gov.au
